Recently, it has been shown that most IBM patients present T-cells expressing CD57, a surface marker of T-cell large granular lymphocytic leukemia, and up to one-third of IBM patients in a cohort met criteria for this type of leukemia, with cytopenias.35 The gene discussed is B3GAT1; the disease is inclusion body myositis.